Insmed: Q4 Earnings Snapshot

BRIDGEWATER, N.J. (AP) — BRIDGEWATER, N.J. (AP) — Insmed Inc. (INSM) on Thursday reported a loss of $186.1 million in its fourth quarter.

The Bridgewater, New Jersey-based company said it had a loss of $1.28 per share.

The results missed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.13 per share.

The biopharmaceutical developing inhaled treatments for patients battling rare lung diseases posted revenue of $83.7 million in the period, also falling short of Street forecasts. Three analysts surveyed by Zacks expected $83.8 million.

For the year, the company reported a loss of $749.6 million, or $5.34 per share. Revenue was reported as $305.2 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on INSM at